Heron Therapeutics, Inc. (HRTX) Cash Flow Statement
Heron Therapeutics, Inc. (HRTX) generated -$11.6M of operating cash flow over the twelve months to 2026-06-30, spent $529000 on capital expenditure and had free cash flow of -$12.1M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
HRTXHeron Therapeutics, Inc.Follow HRTX — free
—
Price chart with a free account
- Market cap
- 57.5M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 10 Nov, in 17 days
| Line | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -191.8 | -124.6 | -184.8 | -203.4 | -146.9 | -58.8 | -22.5 | -27.6 | -11.6 | |
| Capital expenditure | 9.2 | 7.2 | 6.8 | 3.0 | 1.8 | 1.5 | 1.7 | 0.3 | -0.5 | |
| Free cash flow | -201.0 | -131.7 | -191.6 | -206.4 | -148.7 | -60.3 | -24.2 | -27.9 | -12.1 | |
| Stock-based compensation | 33.4 | 51.4 | 50.2 | 46.9 | 43.0 | 32.9 | 13.0 | 10.3 | — |
USD millions · SEC XBRL
Heron Therapeutics, Inc. — questions
- What is Heron Therapeutics, Inc.'s operating cash flow?
- -$11.6M over the twelve months to 2026-06-30.
- How much does Heron Therapeutics, Inc. spend on capital expenditure?
- $529000 over the twelve months to 2026-06-30.
- What is Heron Therapeutics, Inc.'s free cash flow?
- -$12.1M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from Heron Therapeutics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.